What is IRIX's earnings growth forecast for 2025-2025?
(NASDAQ: IRIX) Iridex's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Iridex's earnings in 2025 is -$5,087,000.
In 2025, IRIX is forecast to generate -$4,734,121 in earnings, with the lowest earnings forecast at -$4,548,469 and the highest earnings forecast at -$4,873,360.
What is IRIX's revenue growth forecast for 2025-2025?
(NASDAQ: IRIX) Iridex's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Iridex's revenue in 2025 is $50,647,000.
In 2025, IRIX is forecast to generate $917,016,726 in revenue, with the lowest revenue forecast at $881,055,286 and the highest revenue forecast at $943,987,807.
What is IRIX's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: IRIX) forecast ROA is -16.7%, which is lower than the forecast US Medical Devices industry average of 8.55%.
What is IRIX's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: IRIX) Iridex's current Earnings Per Share (EPS) is -$0.30. In 2025, IRIX's EPS is forecast to hit -$0.28 (min: -$0.26, max: -$0.28).
What is IRIX's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: IRIX) forecast ROE is -101.13%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.